Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Nomenclature for kidney function and disease: executive summary from a KDIGO consensus conference

Nature Reviews Nephrology volume 16, pages 427–428 (2020)Cite this article

Subjects

An obligation of medical journals is the responsible, professional and expeditious delivery of knowledge from researchers and practitioners to the community. The task of editors, therefore, rests not merely in selecting what to publish, but in judging how it might best be communicated. The challenge of improving descriptions of kidney function and disease in medical publishing was the impetus for a KDIGO consensus conference. The conference goals included standardizing and refining kidney-related nomenclature and developing a glossary to be used by journals.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kidney Disease: International Global Outcomes. Consensus Conference on Nomenclature for Kidney Function & Disease. https://kdigo.org/conferences/nomenclature/ (2019)

  2. Plantinga, L. C. et al. Arch. Intern. Med. 168, 2268–2275 (2008).

    Article  Google Scholar 

  3. James, S. L. Lancet 392, 1789–1858 (2018).

    Article  Google Scholar 

  4. GBD Chronic Kidney Disease Collaboration. Lancet 395, 709–733 (2020).

    Article  Google Scholar 

  5. Saran, R. et al. Am. J. Kidney Dis. 71 (3 Suppl. 1), S1–S676 (2018).

    Google Scholar 

  6. Hsu, C. Y. & Chertow, G. M. Am. J. Kidney Dis. 36, 415–418 (2000).

    Article  CAS  Google Scholar 

  7. Levey, A. et al. Kidney Int. https://doi.org/10.1016/j.kint.2020.02.010 (2020).

    Article  PubMed  Google Scholar 

  8. Institute of Medicine Committee on Quality of Healthcare in America. Crossing the Quality Chasm: A New Health System for the 21st Century (National Academies Press, 2001).

Download references

Acknowledgements

The authors are grateful to Juhi Chaudhari, Tufts Medical Center, Boston, for assistance with manuscript preparation before submission. The conference was sponsored by KDIGO and was in part supported by unrestricted educational grants from AstraZeneca, Bayer HealthCare, Boehringer Ingelheim, Fresenius Medical Care, Roche and Sanofi. The content of this article does not necessarily reflect the views or opinions of the organizations or journals that were represented at the conference. Responsibility for the information and views expressed is limited to the coauthors. Note that this Comment article is being published concurrently in multiple journals and serves as an executive summary of the full report published in Kidney International (Levey, A. et al. Kidney Int. https://doi.org/10.1016/j.kint.2020.02.010 (2020)). These articles cover identical concepts but vary in minor stylistic and spelling changes, detail and length of manuscript, in keeping with each journal’s style. Excerpts are adapted with permission of KDIGO and the International Society of Nephrology.

Author information

Authors and Affiliations

  1. Division of Nephrology, Tufts Medical Center, Boston, MA, USA

    Andrew S. Levey

  2. Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany

    Kai-Uwe Eckardt

  3. Managing Editor, American Journal of Kidney Diseases, University of Pennsylvania, Philadelphia, PA, USA

    Nijsje M. Dorman

  4. Managing Editor, The Journal of the American Medical Association, JAMA Network, Chicago, IL, USA

    Stacy L. Christiansen

  5. KDIGO, Brussels, Belgium

    Michael Cheung

  6. Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium

    Michel Jadoul

  7. Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Wolfgang C. Winkelmayer

Authors
  1. Andrew S. Levey
    View author publications

    Search author on:PubMed Google Scholar

  2. Kai-Uwe Eckardt
    View author publications

    Search author on:PubMed Google Scholar

  3. Nijsje M. Dorman
    View author publications

    Search author on:PubMed Google Scholar

  4. Stacy L. Christiansen
    View author publications

    Search author on:PubMed Google Scholar

  5. Michael Cheung
    View author publications

    Search author on:PubMed Google Scholar

  6. Michel Jadoul
    View author publications

    Search author on:PubMed Google Scholar

  7. Wolfgang C. Winkelmayer
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Andrew S. Levey or Kai-Uwe Eckardt.

Ethics declarations

Competing interests

A.S.L. has received research support from AstraZeneca, NIDDK and NKF. K.U.E. has received consultancy fees from Akebia, Bayer and Genzyme; speaker honoraria from Bayer and Vifor; and research support from Amgen, AstraZeneca, Bayer, Fresenius Medical Care and Genzyme. N.M.D. has equity ownership/stock options from Eli Lilly & Co. M.J. has received consultancy fees from Astellas, AstraZeneca, GlaxoSmithKline, MSD and Vifor Fresenius Medical Care Renal Pharma; speaker honoraria from Abbvie, Amgen, Menarini, MSD and Vifor Fresenius Medical Care Renal Pharma; travel support from Amgen; and research support from Alexion, Amgen, Janssen-Cilag, Otsuka and Roche. W.C.W. has received consultancy fees from Akebia, AMAG, Amgen, AstraZeneca, Bayer, Daiichi-Sankyo, Relypsa and ZS Pharma; speaker honoraria from FibroGen; and research support from NIH. The other authors declare no competing interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levey, A.S., Eckardt, KU., Dorman, N.M. et al. Nomenclature for kidney function and disease: executive summary from a KDIGO consensus conference. Nat Rev Nephrol 16, 427–428 (2020). https://doi.org/10.1038/s41581-020-0290-9

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41581-020-0290-9

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing